Despite their success, immune checkpoint blockers (ICB) benefit only a subset of patients and pose potential risk of serious immune-related adverse events, underscoring the critical need for new strat
Many cancers recruit monocytes/macrophages and polarize them into tumor-associated macrophages (TAMs). TAMs promote tumor growth and metastasis and inhibit cytotoxic T cells, preventing immune control
Parameter Estimates for Multinomial Logistic Regression. Parameter Estimates for Cox Proportional Hazards Model of Overall Survival. Parameter Estimates for Cox Proportional Hazards Model of Progre
Diverse combination therapies are being investigated to overcome the limitations of immune checkpoint inhibitors. However, determining the optimal combination therapy remains a challenge. Herein, we d
The notes field contains the full MEDLINE (Ovid) search strategy for patient reported outcomes AND cancer immunotherapy. The file in this dataset contains the full Ovid MEDLINE, Ovid Embase, Ovid Psyc
